 Subjects -> PATENTS, TRADEMARKS AND COPYRIGHTS (Total: 28 journals)
|
|
|
- A patent review of histone deacetylase 8 (HDAC8) inhibitors
(2013–present)-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Suvankar Banerjee Balaram Ghosh Tarun Jha Nilanjan Adhikari a Natural Science Laboratory; Division of Medicinal Science-Pilani, Hyderabad, India
Pages: 1 - 27
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2024-08-21T05:04:52Z
DOI: 10.1080/13543776.2024.2391289
- Tetrahydroisoquinolines – an updated patent review for cancer
treatment (2016 – present)-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Ankur Kumar Tanwar Neha Sengar Nobuyuki Mase Inder Pal Singh a Departments of Natural Products; National Institute of Pharmaceutical Education Technology, Shizuoka University, Hamamatsu, Shizuoka, Japan
Pages: 1 - 34
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2024-08-19T12:25:21Z
DOI: 10.1080/13543776.2024.2391288
- SGLT2 inhibitors for the treatment of diabetes: a patent review
(2019–23)-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Rahul Baghel Nikita Chhikara Pawan Kumar Akhilesh Kumar Tamrakar a Division of Biochemistry; Innovative Research (AcSIR) Ghaziabad, Ghaziabad, India
Pages: 1 - 17
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2024-08-02T11:49:10Z
DOI: 10.1080/13543776.2024.2379929
- Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson’s disease:
a patent review of the literature to date-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Margaux Morez Antonio Jesús Lara Ordóñez Patricia Melnyk Maxime Liberelle Nicolas Lebègue Jean-Marc Taymans University Lille; Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France
Pages: 1 - 16
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2024-07-19T03:08:40Z
DOI: 10.1080/13543776.2024.2378076
- A patent review of small molecule CDK4/6 inhibitors in the treatment of
cancer: 2020–present-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Xiaoling Huang Shidi Xu Lei Duan Shan Xu Wufu Zhu Jiangxi Provincial Key Laboratory of Drug Design; Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi, China
Pages: 1 - 18
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2024-07-18T06:32:16Z
DOI: 10.1080/13543776.2024.2379926
- Progress with polo-like kinase (PLK) inhibitors: a patent review
(2018–present)-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Shirong Bian Ru Zhang Jianyu Nie Mingxing Zhu Zhouling Xie Chenzhong Liao Qin Wang a Department of Pharmaceutical Sciences; Neck Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
Pages: 1 - 18
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2024-07-15T02:58:37Z
DOI: 10.1080/13543776.2024.2379924
- The therapeutic potential of phosphodiesterase 9 (PDE9) inhibitors: a
patent review (2018-present)-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Chen Zhang Zhao-Hang Xue Wei-Hao Luo Mei-Yan Jiang Yinuo Wu a School of Chemistry; Development, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, P. R. China
Pages: 1 - 14
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2024-07-09T12:36:04Z
DOI: 10.1080/13543776.2024.2376632
- Selective COX-2 inhibitors as anticancer agents: a patent review
(2018-2023)-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Mohammad Mahboubi-Rabbani Amir Hossein Abdolghaffari Mahsa Ghesmati Ali Amini Afshin Zarghi a Department of Medicinal Chemistry; Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iranb Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iranc GI Pharmacology Interest Group (GPIG), Universal Scientific Education Research Network (USERN), Tehran, Irand Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Pages: 1 - 25
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2024-07-03T01:04:34Z
DOI: 10.1080/13543776.2024.2373771
|
Hybrid journal (It can contain Open Access articles)
